Ignite Creation Date:
2024-07-17 @ 11:09 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493019
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-17
Brief Title:
Study of Pembrolizumab Carboplatin Paclitaxel and Radiation for the Treatment of Early-Stage Anal Cancer
Sponsor:
Dustin Deming
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
BTCRC-GI22-588
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dustin Deming
Lead Sponsor Class:
OTHER
Responsible Party:
Dustin Deming
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |
| University of Wisconsin Madison | OTHER |